Clinical Laserthermia Systems AB (publ) (CLS-B) — Working Capital to Net Assets Ratio
Clinical Laserthermia Systems AB (publ) (CLS-B) has a Working Capital to Net Assets ratio of 43.8% as of December 2025. Working capital of Skr29.12 Million (current assets of Skr39.12 Million minus current liabilities of Skr10.00 Million) is measured against net assets of Skr66.48 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See net asset quality index of Clinical Laserthermia Systems AB (publ) to measure how much of total assets are equity-financed.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Clinical Laserthermia Systems AB (publ) Working Capital to Net Assets (2008–2025)
This chart shows how Clinical Laserthermia Systems AB (publ)'s Working Capital to Net Assets ratio has evolved across 18 annual periods from 2008 to 2025. As of December 2025, the ratio stands at 43.8%, reflecting working capital of Skr29.12 Million against net assets of Skr66.48 Million SEK. Check CLS-B intangible-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Annual Working Capital to Net Assets for Clinical Laserthermia Systems AB (publ) (2008–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for Clinical Laserthermia Systems AB (publ) from 2008 to 2025, covering 18 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see Clinical Laserthermia Systems AB (publ) (CLS-B) market capitalisation.
| Year | WC/NA Ratio | Working Capital (SEK) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 43.8% | Skr29.12 Million | Skr66.48 Million | Skr39.12 Million | Skr10.00 Million | ▲ +4.9 pp |
| 2024 | 38.9% | Skr25.54 Million | Skr65.69 Million | Skr38.41 Million | Skr12.87 Million | ▲ +8.6 pp |
| 2023 | 30.3% | Skr13.17 Million | Skr43.53 Million | Skr27.14 Million | Skr13.97 Million | ▲ +251.2 pp |
| 2022 | -220.9% | Skr-17.38 Million | Skr7.87 Million | Skr24.26 Million | Skr41.64 Million | ▼ -206.6 pp |
| 2021 | -14.3% | Skr-3.03 Million | Skr21.18 Million | Skr42.42 Million | Skr45.45 Million | ▲ +51.3 pp |
| 2020 | -65.6% | Skr-9.13 Million | Skr13.93 Million | Skr20.90 Million | Skr30.03 Million | ▲ +199.0 pp |
| 2019 | -264.6% | Skr-18.51 Million | Skr7.00 Million | Skr12.55 Million | Skr31.06 Million | ▼ -313.0 pp |
| 2018 | 48.4% | Skr24.09 Million | Skr49.81 Million | Skr31.30 Million | Skr7.21 Million | ▲ +18.5 pp |
| 2017 | 29.9% | Skr9.85 Million | Skr33.00 Million | Skr20.40 Million | Skr10.54 Million | ▲ +47.3 pp |
| 2016 | -17.5% | Skr-2.98 Million | Skr17.06 Million | Skr7.26 Million | Skr10.24 Million | ▼ -22.1 pp |
| 2015 | 4.6% | Skr901.59K | Skr19.46 Million | Skr3.71 Million | Skr2.81 Million | ▼ -42.4 pp |
| 2014 | 47.1% | Skr14.86 Million | Skr31.58 Million | Skr20.24 Million | Skr5.38 Million | ▲ +1.8 pp |
| 2013 | 45.3% | Skr11.81 Million | Skr26.09 Million | Skr14.84 Million | Skr3.04 Million | ▲ +15.2 pp |
| 2012 | 30.1% | Skr5.14 Million | Skr17.09 Million | Skr8.04 Million | Skr2.89 Million | ▲ +21.9 pp |
| 2011 | 8.2% | Skr890.04K | Skr10.83 Million | Skr2.92 Million | Skr2.03 Million | ▼ -13.0 pp |
| 2010 | 21.2% | Skr2.19 Million | Skr10.36 Million | Skr3.39 Million | Skr1.20 Million | ▲ +11.1 pp |
| 2009 | 10.1% | Skr667.09K | Skr6.63 Million | Skr1.65 Million | Skr983.65K | ▼ -22.1 pp |
| 2008 | 32.2% | Skr1.18 Million | Skr3.68 Million | Skr2.23 Million | Skr1.05 Million | — |